FDA flags issues at Coherus partner’s China manufacturing site for cancer drug May 31, 2023
May 31 (Reuters) - Coherus BioSciences Inc (CHRS.O) said on Wednesday that the U.S. Food and Drug Administration (FDA) flagged three observations at its partner Shanghai Junshi Biosciences Ltd's ...